CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and internationally.
Share Price & News
How has CHC Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4164 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 4164's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 4164 underperformed the TW Healthcare industry which returned -3.2% over the past year.
Return vs Market: 4164 underperformed the TW Market which returned 34.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is CHC Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall StIf You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%
7 months ago | Simply Wall StCHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
7 months ago | Simply Wall StShould CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?
CHC Healthcare Group Fundamentals Summary
|4164 fundamental statistics|
Is 4164 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4164 income statement (TTM)|
|Cost of Revenue||NT$1.62b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||2.51|
|Net Profit Margin||15.63%|
How did 4164 perform over the long term?See historical performance and comparison
5.7%Current Dividend Yield
Is CHC Healthcare Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 4164 (NT$35.25) is trading below our estimate of fair value (NT$43.1)
Significantly Below Fair Value: 4164 is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: 4164 is good value based on its PE Ratio (14.4x) compared to the TW Healthcare industry average (18.2x).
PE vs Market: 4164 is good value based on its PE Ratio (14.4x) compared to the TW market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4164's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4164 is good value based on its PB Ratio (0.9x) compared to the TW Healthcare industry average (1.8x).
How is CHC Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CHC Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has CHC Healthcare Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4164 has high quality earnings.
Growing Profit Margin: 4164's current net profit margins (15.6%) are higher than last year (14.3%).
Past Earnings Growth Analysis
Earnings Trend: 4164's earnings have grown significantly by 26.4% per year over the past 5 years.
Accelerating Growth: 4164's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4164 had negative earnings growth (-2.5%) over the past year, making it difficult to compare to the Healthcare industry average (-2.8%).
Return on Equity
High ROE: 4164's Return on Equity (6.2%) is considered low.
How is CHC Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: 4164's short term assets (NT$3.6B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 4164's short term assets (NT$3.6B) do not cover its long term liabilities (NT$4.5B).
Debt to Equity History and Analysis
Debt Level: 4164's debt to equity ratio (72.5%) is considered high.
Reducing Debt: 4164's debt to equity ratio has reduced from 77.3% to 72.5% over the past 5 years.
Debt Coverage: 4164's debt is well covered by operating cash flow (20.5%).
Interest Coverage: 4164's interest payments on its debt are well covered by EBIT (10.9x coverage).
What is CHC Healthcare Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4164's dividend (5.69%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).
High Dividend: 4164's dividend (5.69%) is in the top 25% of dividend payers in the TW market (5.26%)
Stability and Growth of Payments
Stable Dividend: 4164 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4164 has only been paying a dividend for 9 years, and since then payments have fallen.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (80%), 4164's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Pei-Lin Lee is Legal Director Representative of Huan Rui Medical Investment Holdings Co., Ltd. Mr. Lee has been Chairman of CHC Healthcare Group since November 25, 2012 and serves as its President. Mr....
CEO Compensation Analysis
Compensation vs Market: Pei-Lin's total compensation ($USD422.87K) is above average for companies of similar size in the TW market ($USD174.39K).
Compensation vs Earnings: Pei-Lin's compensation has been consistent with company performance over the past year.
Experienced Management: 4164's management team is considered experienced (3.2 years average tenure).
Experienced Board: 4164's board of directors are considered experienced (9.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11%.
CHC Healthcare Group's company bio, employee growth, exchange listings and data sources
- Name: CHC Healthcare Group
- Ticker: 4164
- Exchange: TWSE
- Founded: 1977
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: NT$5.509b
- Shares outstanding: 156.29m
- Website: https://www.chengyeh.com
- CHC Healthcare Group
- No. 366, Changchun Road
- 6th Floor
CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and i...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/16 15:36|
|End of Day Share Price||2021/09/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.